ArticleKidney medicine2026

Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study.

Timna Agur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.